Impaired transforming growth factor-β signaling in idiopathic pulmonary arterial hypertension

American Journal of Respiratory and Critical Care Medicine

Volumn 170, Issue 12, 2004, Pages 1340-1348

  Richter, Amy ^b   Yeager, Michael E ^b   Zaiman, Ari ^b   Cool, Carlyne D ^b   Voelkel, Norbert F ^b   Tuder, Rubin M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Endothelial cells; Pulmonary hypertension; Smad; Smooth muscle cells; Transforming growth factor

Indexed keywords

SMAD PROTEIN; SMAD1 PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; CONTROLLED STUDY; EMPHYSEMA; ENDOTHELIUM CELL; ESSENTIAL HYPERTENSION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTIMA; POPULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PULMONARY ARTERY; PULMONARY HYPERTENSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ARTERIES; HUMANS; HYPERTENSION, PULMONARY; TRANSFORMING GROWTH FACTOR BETA;

EID: 10644256482     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200311-1602OC     Document Type: Article

References (35)

1. Tuder RM, Yeager ME, Geraci M, Golpon HA, Voelkel NF. Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene. Eur Respir J 2001;17:1065-1069.
2. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, Gibbs S, Lebrec D, Speich R, Beghetti M. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004;43:S5-S12.
3. Deng Z, Morse JH, Slager SL, Cuervo N, Moore KJ, Venetos G, Kalachikov S, Cayanis E, Fischer SG, Barst RJ, et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 2000;67:737-744.
4. Lane KB, Machado RD, Pauciulo MW, Thomson JR, Phillips JA III, Loyd JE, Nichols WC, Trembath RC, International PPH Consortium. Heterozygous germline mutations in BMPR2 encoding a TGF-β receptor cause familial pulmonary hypertension. Nat Genet 2000;26:81-84.
5. Yeager ME, Halley GR, Golpon HA, Voelkel NF, Tuder RM. Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension. Circ Res 2001;88:e8-e11.
6. Trembath RC, Thomson JR, Machado RD, Morgan NV, Atkinson C, Winship I, Simonneau G, Galie N, Loyd JE, Humbert M, et al. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2001;2001:325-334.
7. Du L, Sullivan CC, Chu D, Cho AJ, Kido M, Wolf PL, Yuan JX, Deutsch R, Jamieson SW, Thistlethwaite PA. Signaling molecules in nonfamilial pulmonary hypertension. N Engl J Med 2003;348:500-509.
8. Massague J, Blain SW, Lo RS. TGF-β signaling in growth control, cancer, and heritable disorders. Cell 2000;103:295-309.
9. Massague J, Chen YG. Controlling TGF-β signaling. Genes Dev 2000;14:627-644.
10. Padgett RW, Das P, Krishna S. TGF-β signaling, Smads, and tumor suppressors. Bioessays 1998;20:382-390.
11. Atkinson C, Stewart S, Upton PD, Machado R, Thomson JR, Trembath RC, Morrell NW. Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of Type II bone morphogenetic protein receptor. Circulation 2002;105:1672-1678.
12. Richter A, Yeager M, Voelkel NF, Tuder RM. Impaired TGF-β receptor signaling in plexiform lesions of lungs with primary pulmonary hypertension (PPH) [abstract]. Am J Respir Crit Care Med 2003;167:A710.
13. Cool CD, Rai MD, Yeager ME, Hernandez-Saavedra D, Serls AE, Bull TM, Geraci MW, Brown KK, Routes JM, Tuder RM, et al. Expression of human herpesvirus 8 in primary pulmonary hypertension. N Engl J Med 2003;349:1113-1122.
14. Rosendahl A, Checchin D, Fehniger TE, ten Dijke P, Heldin CH, Sideras P. Activation of the TGF-β/activin-Smad2 pathway during allergic airway inflammation. Am J Respir Cell Mol Biol 2001;25:60-68.
15. Rosendahl A, Pardali E, Speletas M, ten Dijke P, Heldin CH, Sideras P. Activation of bone morphogenetic protein/Smad signaling in bronchial epithelial cells during airway inflammation. Am J Respir Cell Mol Biol 2002;27:160-169.
16. Santos S, Peinado VI, Ramirez J, Melgosa T, Roca J, Rodriguez-Roisin R, Barbera JA. Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD. Eur Respir J 2002;19:632-638.
17. Pietra GG, Capron F, Stewart S, Leone O, Humbert M, Robbins IM, Reid LM, Tuder RM. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol 2004;43:25S-32S.
18. Tuder RM, Groves BM, Badesch DB, Voelkel NF. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 1994;144:275-285.
19. Cool CD, Stewart JS, Werahera P, Miller GJ, Williams RL, Voelkel NF, Tuder RM. Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell specific markers: evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol 1999;155:411-419.
20. Tuder RM, Chacon M, Alger LA, Wang J, Taraseviciene-Stewart L, Kasahara Y, Cool CD, Bishop AE, Geraci MW, Semenza GL, et al. Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis. J Pathol 2001;195:367-374.
21. Shi YG, Massague J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 2003;113:685-700.
22. Loscalzo J. Genetic clues to the cause of primary pulmonary hypertension. N Engl J Med 2001;345:367-371.
23. Botney MD, Bahadori L, Gold LI. Vascular remodeling in primary pulmonary hypertension: potential role for transforming growth factor-β. Am J Pathol 1994;144:286-295.
24. Kang SH, Bang YJ, Jong HS, Seo JY, Kim NK, Kim SJ. Rapid induction of p21WAF1 but delayed down-regulation of Cdc25A in the TGF-β-induced cell cycle arrest of gastric carcinoma cells. Br J Cancer 1999; 80:1144-1149.
25. 1 down-regulates vascular endothelial growth factor receptor2/flk-1 expression in vascular endothelial cells. J Biol Chem 1996;271:11500-11505.
26. DeRuiter MC, Poelmann RE, VanMunsteren JC, Mironov V, Markwald RR, Gittenberger-de Groot AC. Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ Res 1997;80:444-451.
27. Frid MG, Kale VA, Stenmark KR. Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis. Circ Res 2002;90:1189-1196.
28. Schwarte-Waldhoff I, Volpert OV, Bouck NP, Sipos B, Hahn SA, Klein-Scory S, Luttges J, Kloppel G, Graeven U, Eilert-Micus C, et al. Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. Proc Natl Acad Sci USA 2000;97:9624-9629.
29. Tuder RM, Cool CD, Yeager ME, Taraseviciene-Stewart L, Bull TM, Voelkel NF. The pathobiology of pulmonary hypertension: endothelium. Chest Clin North Am 2001;22:405-418.
30. Teichert-Kuliszewska K, Wijeysundera HV, Karoubi G, Stewart DJ. Mutations in BMPRII decrease pulmonary microvascular endothelial cell survival and increase smooth muscle cell growth: double jeopardy for pulmonary hypertension. Cardiovasc Pathol 2004;13:S79.
31. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P. Balancing the activation state of the endothelium via two distinct TGF-β Type I receptors. EMBO J 2002;21:1743-1753.
32. Xu W, Angelis K, Danielpour D, Haddad MM, Bischof O, Campisi J, Stavnezer E, Medrano EE. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to Type β transforming growth factor. Proc Natl Acad Sci USA 2000;97:5924-5929.
33. Stroschein SL, Wang W, Zhou S, Zhou Q, Luo K. Negative feedback regulation of TGF-β signaling by the SnoN oncoprotein. Science 1999; 286:771-774.
34. Sun Y, Liu X, Ng-Eaton E, Lodish HF, Weinberg RA. SnoN and ski protooncoproteins are rapidly degraded in response to transforming growth factor β signaling. Proc Natl Acad Sci USA 1999;6:12442-12447.
35. Roberts AB. The ever-increasing complexity of TGF-β signaling. Cytokine Growth Factor Rev 2002;13:3-5.